Ocugen Inc (OCGN)
1.24
+0.01
(+0.81%)
USD |
NASDAQ |
Apr 23, 16:00
1.23
-0.01
(-0.81%)
After-Hours: 18:56
Ocugen Debt to Equity Ratio: 0.069 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.069 |
| September 30, 2023 | 0.0475 |
| June 30, 2023 | 0.039 |
| March 31, 2023 | 0.0305 |
| December 31, 2022 | 0.0309 |
| September 30, 2022 | 0.0238 |
| June 30, 2022 | 0.0153 |
| March 31, 2022 | 0.0132 |
| December 31, 2021 | 0.0179 |
| September 30, 2021 | 0.0158 |
| June 30, 2021 | 0.0144 |
| March 31, 2021 | 0.0447 |
| December 31, 2020 | 0.0955 |
| September 30, 2020 | 0.2188 |
| June 30, 2020 | 0.4163 |
| March 31, 2020 | 0.2166 |
| December 31, 2019 | 0.0973 |
| September 30, 2019 | -0.0808 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.0022 |
| December 31, 2017 | -0.0158 |
| September 30, 2017 | -0.0673 |
| June 30, 2017 | 0.5831 |
| March 31, 2017 | 0.0882 |
| December 31, 2016 | 0.0561 |
| September 30, 2016 | 0.2247 |
| June 30, 2016 | 0.0817 |
| March 31, 2016 | 0.0582 |
| December 31, 2015 | 0.0477 |
| September 30, 2015 | 0.0412 |
| June 30, 2015 | 0.0373 |
| March 31, 2015 | 0.0339 |
| December 31, 2014 | 0.0323 |
| September 30, 2014 | 0.1152 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0808
Minimum
Sep 2019
0.4163
Maximum
Jun 2020
0.0698
Average
0.0309
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.4265 |
| Akebia Therapeutics Inc | -1.134 |
| Shockwave Medical Inc | 1.094 |
| Imunon Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 64.55M |
| Total Liabilities (Quarterly) | 23.98M |
| Shareholders Equity (Quarterly) | 40.56M |
| Current Ratio | 2.514 |
| Net Debt Paydown Yield | -0.07% |